{"id":27165,"date":"2022-12-07T13:58:18","date_gmt":"2022-12-07T18:58:18","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_events&#038;p=27165"},"modified":"2022-12-23T06:26:48","modified_gmt":"2022-12-23T11:26:48","slug":"cri-speaks-biotech-showcase-2023","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/cri-speaks-biotech-showcase-2023","title":{"rendered":"CRI Speaks: Biotech Showcase 2023"},"content":{"rendered":"\n<p>CRI Anna-Maria Kellen Clinical Accelerator and Venture Fund Managing Director Jay Campbell will moderate a panel titled, \u00ab<a href=\"Moving Faster and Smarter to Improve Patient Outcomes\" target=\"_blank\" rel=\"noreferrer noopener\">Oncology: Moving Faster and Smarter to Improve Patient Outcomes<\/a>\u00bb  on accelerating cancer therapeutics development on January 9, 2023. Panelists include Stacy Blain, CEO of Concarlo Therapeutics, Michael Goldberg, CEO of Surge Therapeutics, and Crystal Mackall, professor of pediatrics and medicine at Stanford University.<\/p>\n\n\n","protected":false},"excerpt":{"rendered":"<p>CRI Clinical Accelerator and Venture Fund Managing Director Jay Campbell will moderate a panel discussion on accelerating cancer therapeutics development.<\/p>\n","protected":false},"featured_media":27325,"template":"","events_categories":[422],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-27165","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-eventos-del-cri"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CRI Speaks: Biotech Showcase 2023 - Cancer Research Institute<\/title>\n<meta name=\"description\" content=\"CRI Clinical Accelerator and Venture Fund Managing Director Jay Campbell will moderate a panel discussion on accelerating cancer therapeutics development. Panelists include Stacy Blain, CEO of Concarlo Therapeutics, Michael Goldberg, CEO of Surge Therapeutics, and Crystal Mackall, professor of pediatrics and medicine at Stanford University.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRI Speaks: Biotech Showcase 2023 - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"CRI Clinical Accelerator and Venture Fund Managing Director Jay Campbell will moderate a panel discussion on accelerating cancer therapeutics development. Panelists include Stacy Blain, CEO of Concarlo Therapeutics, Michael Goldberg, CEO of Surge Therapeutics, and Crystal Mackall, professor of pediatrics and medicine at Stanford University.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-23T11:26:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/12\/Biotech_Showcase_2023_tile.png\" \/>\n\t<meta property=\"og:image:width\" content=\"810\" \/>\n\t<meta property=\"og:image:height\" content=\"464\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023\",\"name\":\"CRI Speaks: Biotech Showcase 2023 - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/12\/Biotech_Showcase_2023_tile.png\",\"datePublished\":\"2022-12-07T18:58:18+00:00\",\"dateModified\":\"2022-12-23T11:26:48+00:00\",\"description\":\"CRI Clinical Accelerator and Venture Fund Managing Director Jay Campbell will moderate a panel discussion on accelerating cancer therapeutics development. Panelists include Stacy Blain, CEO of Concarlo Therapeutics, Michael Goldberg, CEO of Surge Therapeutics, and Crystal Mackall, professor of pediatrics and medicine at Stanford University.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/12\/Biotech_Showcase_2023_tile.png\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/12\/Biotech_Showcase_2023_tile.png\",\"width\":810,\"height\":464},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CRI Speaks: Biotech Showcase 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CRI Speaks: Biotech Showcase 2023 - Cancer Research Institute","description":"CRI Clinical Accelerator and Venture Fund Managing Director Jay Campbell will moderate a panel discussion on accelerating cancer therapeutics development. Panelists include Stacy Blain, CEO of Concarlo Therapeutics, Michael Goldberg, CEO of Surge Therapeutics, and Crystal Mackall, professor of pediatrics and medicine at Stanford University.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023","og_locale":"es_ES","og_type":"article","og_title":"CRI Speaks: Biotech Showcase 2023 - Cancer Research Institute","og_description":"CRI Clinical Accelerator and Venture Fund Managing Director Jay Campbell will moderate a panel discussion on accelerating cancer therapeutics development. Panelists include Stacy Blain, CEO of Concarlo Therapeutics, Michael Goldberg, CEO of Surge Therapeutics, and Crystal Mackall, professor of pediatrics and medicine at Stanford University.","og_url":"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023","og_site_name":"Cancer Research Institute","article_modified_time":"2022-12-23T11:26:48+00:00","og_image":[{"width":810,"height":464,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/12\/Biotech_Showcase_2023_tile.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023","url":"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023","name":"CRI Speaks: Biotech Showcase 2023 - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/12\/Biotech_Showcase_2023_tile.png","datePublished":"2022-12-07T18:58:18+00:00","dateModified":"2022-12-23T11:26:48+00:00","description":"CRI Clinical Accelerator and Venture Fund Managing Director Jay Campbell will moderate a panel discussion on accelerating cancer therapeutics development. Panelists include Stacy Blain, CEO of Concarlo Therapeutics, Michael Goldberg, CEO of Surge Therapeutics, and Crystal Mackall, professor of pediatrics and medicine at Stanford University.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/12\/Biotech_Showcase_2023_tile.png","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/12\/Biotech_Showcase_2023_tile.png","width":810,"height":464},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/cri-speaks-biotech-showcase-2023#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"CRI Speaks: Biotech Showcase 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/27165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/27325"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=27165"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=27165"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=27165"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=27165"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=27165"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=27165"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=27165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}